FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study

2.

Children with cancer experience much less pain at home when using a pain monitoring app.

3.

Breast cancer prevention: How nurse practitioners and physician assistants can help

4.

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.

5.

Reduced Suicide Rates in Cancer Patients; Enhanced Circadian Rhythm; HIV Vaccine for Cancer Patients?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot